4.63
Unicycive Therapeutics Inc Aktie (UNCY) Neueste Nachrichten
Unicycive Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 - MarketScreener
Unicycive Therapeutics, Inc. Investors: Company Investigated by the Portnoy Law Firm - GlobeNewswire
Unicycive Posts 65% EPS Gain in Q2 - The Globe and Mail
Unicycive Posts 65% EPS Gain in Q2 - The Motley Fool
Unicycive Therapeutics : August 2025 Corporate Presentation - MarketScreener
Unicycive's Kidney Drug Shows 90% Success Rate Despite FDA Hurdle, Reports $22.3M Cash Position - Stock Titan
Today's SEC FilingsLatest 10-K, 10-Q, 8-K Forms - Stock Titan
Unicycive Therapeutics, Inc. SEC 10-Q Report - TradingView
Can Unicycive Therapeutics Inc. recover in the next quarter2025 Dividend Review & Free Daily Entry Point Trade Alerts - Newser
Quantitative breakdown of Unicycive Therapeutics Inc. recent moveWeekly Market Summary & Momentum Based Trading Ideas - Newser
Top chart patterns to watch in Unicycive Therapeutics Inc.Dip Buying & Reliable Entry Point Alerts - Newser
Unicycive Therapeutics Inc.’s Price Action Aligns with Quant SignalsJuly 2025 Patterns & Entry Point Confirmation Alerts - beatles.ru
What high frequency data says about Unicycive Therapeutics Inc.2025 Geopolitical Influence & AI Based Buy/Sell Signal Reports - Newser
Using Python tools to backtest Unicycive Therapeutics Inc. strategiesJuly 2025 Earnings & Precise Buy Zone Identification - Newser
Why Unicycive Therapeutics Inc. stock attracts strong analyst attentionCPI Data & Fast Gaining Stock Strategy Reports - Newser
Momentum divergence signals in Unicycive Therapeutics Inc. chart2025 Historical Comparison & AI Driven Stock Movement Reports - Newser
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Unicycive - Bluefield Daily Telegraph
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Unicycive Therapeutics, Inc. - FinancialContent
Why Unicycive Therapeutics Inc. is moving today2025 Major Catalysts & Free Growth Oriented Trading Recommendations - Newser
Will Unicycive Therapeutics Inc. bounce back from current supportM&A Rumor & High Conviction Trade Alerts - Newser
Real time pattern detection on Unicycive Therapeutics Inc. stockLong Term Equity Screener with Safety Metrics - Newser
Is it time to cut losses on Unicycive Therapeutics Inc.Machine Learning Intraday Signal Forecast - Newser
Does Unicycive Therapeutics Inc. fit your quant trading modelEntry Timing with Downside Risk Analysis - Newser
Does Unicycive Therapeutics Inc. qualify in momentum factor screeningFree High Growth Low Risk Stock Selection - Newser
How to integrate Unicycive Therapeutics Inc. into portfolio analysis toolsFree Scalable Portfolio Growth Suggestions - Newser
Is a relief rally coming for Unicycive Therapeutics Inc. holdersBreakout Watcher with Entry and Exit Alerts - Newser
Technical signs of recovery in Unicycive Therapeutics Inc.Free Real Profit Trade Plan Suggestions - Newser
Will breakout in Unicycive Therapeutics Inc. lead to full recoveryStock Price Prediction Using AI Tools - Newser
Is Unicycive Therapeutics Inc. impacted by rising ratesFree Screener for Explosive Stocks - thegnnews.com
Institutional scanner results for Unicycive Therapeutics Inc.Free Stable Entry High Return Opportunities - Newser
Real time social sentiment graph for Unicycive Therapeutics Inc.Long-Term Stock Growth Forecast Insights - Newser
Bronstein, Gewirtz & Grossman, LLC Is Investigating Unicycive Therapeutics, Inc. (UNCY) And Encourages Shareholders to Connect - ACCESS Newswire
Unicycive Therapeutics: Pomerantz LLP Investigating Securities Fraud Claims - AInvest
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Unicycive Therapeutics, Inc. (UNCY) And Encourages Shareholders to Reach Out - ACCESS Newswire
What drives Unicycive Therapeutics Inc. stock priceNavigate the market with precision tools - Jammu Links News
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Unicycive Therapeutics, Inc. (UNCY) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
Unicycive Therapeutics Inc. Stock Analysis and ForecastBuild wealth faster with expert stock picks - Jammu Links News
What are Unicycive Therapeutics Inc. company’s key revenue driversFind the best stocks for sustainable growth - Jammu Links News
Technical analysis overview for Unicycive Therapeutics Inc. stockPrice Action Summary and Entry Strategy Guide - Newser
What makes Unicycive Therapeutics Inc. stock price move sharplyOutstanding trading profits - Jammu Links News
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):